Description

P&G’s $3.8 Billion Thorne Acquisition Could Reshape Wellness!

Procter & Gamble has agreed to acquire premium supplement maker Thorne from L Catterton in an all-cash transaction valued at $3.8 billion, extending its push into faster-growing health and wellness categories. The transaction, which is expected to close in the fourth quarter of 2026, follows reported interest from other consumer-health groups, including Haleon and Unilever. Thorne, founded in 1984, sells science-backed supplements spanning creatine, prenatal vitamins and other preventive-health applications, and was reportedly on track to generate approximately $650 million in 2026 sales. The acquisition comes as P&G works to restore consistent growth following fiscal 2026 organic sales growth of slightly more than 1%, modest volume gains and uneven performance across several mature household categories. Management has identified Beauty and Health as areas capable of producing comparatively stronger long-term growth. Against that backdrop, Thorne could provide P&G with a premium platform positioned around self-care, prevention, wellness and personalized health.